September 21st, 2014
Parkinson’s Drug Recall
Parkinson’s Drug Recall
September 4, 2014
Nearly 4,000 bottles of a Parkinson’s combination drug are being pulled from shelves, according to the U.S. Food and Drug Administration.
The U.S. nationwide recall is due to what may potentially be ‘superpotent’ carbidopa/levodopatablets.
This recall comes on the heels of a recall in April and June for the Israeli generic drug maker.
References:
1. Teva Recalling ‘Superpotent’ Drug for Parkinson’s Disease. FDANews. 2014 Aug 27.
2. Palmer E. Teva recalls Parkinson's disease drug because it may be 'superpotent'. Fierce Pharma. 2014 Aug 26.
PLN Topics:
Medication Errors
RELATED ARTICLES
Baxter Recalls Potassium Chloride Injection
Heparin Recall Due to Human Hair
Warfarin Sodium Tablets Recall
FDA Issues Reminder to Avoid Products from Texas Compounder
Compounding Pharmacy Recall
- August 20th, 2012
Bone Drug ONJ Triggered by Dental WorkRead - December 22nd, 2012
FDA Issues Pradaxa Valve WarningRead - September 23rd, 2012
2 Beta-Blockers Similar for CV Event RiskRead - November 7th, 2014
Experts Update Stroke Prevention GuidelinesRead - December 31st, 2012
Managing Disruptive Doctors (or How to Handle a Spoiled Brat)Read
Geriatric Nutrition
Without good nutrition, positive drug therapy outcomes are very difficult to obtain, For the best in Geriatric Nutritional Information
Find out more Optima SolutionsContinuing Education
Each month we will post an analysis of specific aspects of government long-term healthcare regulations.
Find out moreHealth care alerts
Video
